| 1 |
34163823 | Phase separation of p53 precedes aggregation and is affected by oncogenic mutations and ligands. | 2021 Apr 26 |
2 |
| 2 |
32325827 | Tumor-Targeted Delivery of the p53-Activating Peptide VIP116 with PEG-Stabilized Lipodisks. | 2020 Apr 19 |
1 |
| 3 |
30554018 | Redox-responsive polymer inhibits macrophages uptake for effective intracellular gene delivery and enhanced cancer therapy. | 2019 Mar 1 |
2 |
| 4 |
30921731 | A lanthanide-peptide-derived bacterium-like nanotheranostic with high tumor-targeting, -imaging and -killing properties. | 2019 Jun |
1 |
| 5 |
26599622 | A surface charge-switchable and folate modified system for co-delivery of proapoptosis peptide and p53 plasmid in cancer therapy. | 2016 Jan |
2 |
| 6 |
22872685 | Combination treatment in vitro with Nutlin, a small-molecule antagonist of MDM2, and pegylated interferon-α 2a specifically targets JAK2V617F-positive polycythemia vera cells. | 2012 Oct 11 |
1 |
| 7 |
17971768 | Combination therapy with PEG-IFN-alpha and 5-FU inhibits HepG2 tumour cell growth in nude mice by apoptosis of p53. | 2007 Dec 3 |
1 |
| 8 |
11813984 | Development of a sensitive assay to detect reversibly oxidized protein cysteine sulfhydryl groups. | 2001 Dec |
1 |
| 9 |
10998350 | p53 protein oxidation in cultured cells in response to pyrrolidine dithiocarbamate: a novel method for relating the amount of p53 oxidation in vivo to the regulation of p53-responsive genes. | 2000 Oct 1 |
1 |